|
|
Volumn 275, Issue 5304, 1997, Pages 1261-1264
|
|
Exploiting the HIV-chemokine nexus
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CD4 ANTIGEN;
CHEMOKINE;
CHEMOKINE RECEPTOR;
GLYCOPROTEIN GP 120;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;
MACROPHAGE INFLAMMATORY PROTEIN 1BETA;
RANTES;
RECEPTOR BLOCKING AGENT;
T LYMPHOCYTE RECEPTOR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
DRUG INDUSTRY;
DRUG RESISTANCE;
GENETIC ENGINEERING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MEDICAL RESEARCH;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
TIGHT JUNCTION;
VACCINATION;
VACCINE PRODUCTION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AIDS VACCINES;
ANIMALS;
ANIMALS, GENETICALLY MODIFIED;
ANTI-HIV AGENTS;
ANTIBODIES, MONOCLONAL;
CHEMOKINES;
DISEASE MODELS, ANIMAL;
DRUG DESIGN;
HIV;
HUMANS;
RECEPTORS, CCR5;
RECEPTORS, CYTOKINE;
RECEPTORS, HIV;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
NEXUS;
|
|
EID: 0031043024
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.275.5304.1261 Document Type: Note |
|
Times cited : (27)
|
|
References (0)
|